|
Page 4 of 4
Truly, the most amazing result of this study is that any significant findings were evident; those that were reported were generally of little clinical significance. Further, from this study, it appears that the negative effects were balanced by other metabolic adaptations such that one could argue that the AAS use promoted greater health. In the end, this study, despite its extensive examinations and long-term data collection, provides little real knowledge about the health risks/benefits of AAS use. Hopefully, the authors will repeat the study looking at changes relative to periods of use and non-use under more uniform conditions. As it stands, we have no idea what impact aromatase inhibitors, GH and insulin have on a person during and after prolonged periods of AAS use. To end on a more positive note, this study certainly did not Reveal any significant negative effects among these AAS-using bodybuilders over a two-year period of use.
References:
1. Grogen S, Shepherd S, et al. Experiences of anabolic steroid use: in-depth interviews with men and women bodybuilders. J Health Psychol, 2006;11:845-56.
2. Maravelias C, Dona A, et al. Adverse effects of anabolic steroids in athletes. A constant threat. Toxicol Lett, 2005;158:167-75.
3. Stimac D, Milic S, et al. Androgenic/Anabolic steroid-induced toxic hepatitis. J Clin Gastroenterol, 2002;35:350-2.
4. Di Paolo M, Agozzino M, et al. Sudden anabolic steroid abuse-related death in athletes. Int J Cardiol, 2007;114:114-7.
5. Fineschi V, Riezzo I, et al. Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med, 2007;121:48-53.
6. Hoffman JR, Ratamess NA. Medical issues associated with anabolic steroid use: are they exaggerated? J Sports Sci Med, 2006;5:182-93.
7. Bhasin S, Woodhouse L, et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab, 2005;90:678-88.
8. Sinha-Hikim I, Artaza J, et al. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab, 2002;283:E154-64.
9. Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem, 1997;43:1262-79.
10. Bonetti A, Tirelli F, et al. Side Effects of Anabolic Androgenic Steroids Abuse. Int J Sports Med, 2007 Nov 14;[Epub ahead of print].
11. Turek PJ, Williams RH, et al. The reversibility of anabolic steroid-induced azoospermia. J Urol, 1995;153:1628-30.
12. Applebaum-Bowden D, Haffner SM, et al. The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high-density lipoprotein2 cholesterol. Metabolism, 1987;36:949-52.
13. Hartgens F, Rietjens G, et al. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sports Med, 2004;38:253-9.
14. Durrington PN. Triglycerides are more important in atherosclerosis than epidemiology has suggested. Atherosclerosis, 1998;141:57-62.
15. Jellinger PS. Metabolic consequences of hyperglycemia and insulin resistance. Clin Cornerstone, 2007;8 Suppl 7:S30-42.
16. Pertusi R, Dickerman RD, et al. Evaluation of aminotransferase elevations in a bodybuilder using anabolic steroids: hepatitis or rhabdomyolysis? J Am Osteopath Assoc, 2001;101:391-4.
17. Coviello AD, Kaplan B, et al. Effects of Graded Doses of Testosterone on Erythropoiesis in Healthy Young and Older Men. J Clin Endocrinol Metab, 2007 Dec 26;[Epub ahead of print].
|
Chemical Enhancement 
